Key Short-Chain PFAS Not Carcinogenic, Not Hormone Disruptor

WASHINGTON (March 18, 2019) – Three new recently published studies supported by FluoroCouncil in the peer-reviewed journal Regulatory Toxicology and Pharmacology support the conclusion that perfluorohexanoic acid (PFHxA), a key short-chain perfluoroalkyl substance (PFAS), presents negligible risk to humans.  These articles offer the latest look at exposure, health effects, and hormone (endocrine) activity related to this particular PFAS, […]

FluoroCouncil: Inappropriate to Regulate Universe of PFAS Chemistries as a Single Class

WASHINGTON (March 1, 2019) – The FluoroCouncil, a global organization representing the world’s leading FluoroTechnology companies, issued the following statement upon the introduction of S.638, sponsored by Senators Tom Carper (D-Del.) and Shelly Moore Capito (R-W.Va.), which seeks to designate all per- and polyfluoroalkyl substances (PFAS) as hazardous substances under the Comprehensive Environmental Response, Compensation, […]